MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-11-0005176
Avolife Pharmaceutical Private Limited
Avolife Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.9 Lakh
▲ 355% YoY
Net loss · FY 2023
₹17
Net margin 0%
EBITDA · FY 2023
₹2,741
EBITDA margin 1.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Avolife Pharmaceutical Private Limited
Data last updated:
Avolife Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2020PTC369596. Its GSTIN is 07AAUCA0093Q1ZY (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sukhwant Singh and Kaisvinder Singh Cheema.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B – 52 Basement B – Block Community Center Janakpuri, Delhi, India – 110058.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.9 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹17 (net margin 0%) and EBITDA of ₹2,741 (EBITDA margin 1.4%).
Avolife Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0005176).
Company details
CIN U24290DL2020PTC369596
Registration Number 369596
Incorporation Date 09 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0005176
Recognitions & Rankings of Avolife Pharmaceutical
Contact details
Avolife Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 52 Basement B – Block Community Center Janakpuri, Delhi, India – 110058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Avolife Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Avolife Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Avolife Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Avolife Pharmaceutical Private Limited, buy the company report.
Financials of Avolife Pharmaceutical Private Limited
FY 2023 filings availableAvolife Pharmaceutical Private Limited reported revenue of ₹1.9 Lakh (up 355% YoY) for FY 2023.
Revenue · FY 2023
₹1.9 Lakh ▲ 355%
Net loss · FY 2023
₹17 margin 0%
EBITDA · FY 2023
₹2,741 margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 355%
EBITDA CAGR growth
1 year
▲ 104%
Revenue rose 355% in the latest year. EBITDA rose 104% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.9 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2,741 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹17 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.4% | ||
| Net Profit Margin | 0% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Avolife Pharmaceutical Private Limited, buy the company report.
Board of directors of Avolife Pharmaceutical Private Limited
Avolife Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sukhwant Singh | Director | 09 Sep 2020 | 6 Years 1 Months | Current |
| Kaisvinder Singh Cheema | Director | 09 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Avolife Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cistron Healthcare and Allied Services Private Limited | ₹1.92 Lakh (FY 2020) | -50.0% | Pune, Maharashtra, India | |||
| Eyedent Enterprises Private Limited | ₹1.91 Lakh (FY 2024) | 3.0% | Nashik, Maharashtra, India | |||
| Sabkhoj Foundation | ₹1.9 Lakh (FY 2024) | 7.0% | Jaipur, Rajasthan, India | |||
| Elaz@Yourhealth Private Limited | ₹1.9 Lakh (FY 2021) | Patna, Bihar, India | ||||
| Bhoomi Ayurveda Private Limited | ₹1.9 Lakh (FY 2025) | -79.0% | New Delhi, Delhi, India | |||
| Avolife Pharmaceutical Private Limitedthis company | ₹1.9 Lakh (FY 2023) | -₹17 | 0% | 355.0% | Delhi, India | |
| Healing Hands Lifecare Private Limited | ₹1.89 Lakh (FY 2018) | -42.0% | Mumbai, Maharashtra, India | |||
| Windivine Healthcare Private Limited | ₹1.89 Lakh (FY 2024) | Thane, Maharashtra, India | ||||
| Biobt Private Limited | ₹1.88 Lakh (FY 2025) | Mohali, Punjab, India | ||||
| Biomoon Lifescience Private Limited | ₹1.88 Lakh (FY 2022) | Vasai, Maharashtra, India | ||||
| X10 Healthcare Private Limited | ₹1.88 Lakh (FY 2025) | Bangalore, Karnataka, India |
To see the full peer comparison of Avolife Pharmaceutical Private Limited, buy the company report.
Auditor
Avolife Pharmaceutical Private Limited is audited by ARUN ARORA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUN ARORA | FY 2023 | 538860 |
Shareholding
The shareholding of Avolife Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Avolife Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avolife Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avolife Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Avolife Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Avolife Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAUCA0093Q1ZY | Delhi | Active | 30 Sep 2020 |
To see the full GST registrations and return filing status of Avolife Pharmaceutical Private Limited, buy the company report.
Recent activity
Avolife Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Kaisvinder Singh Cheema was appointed as Director on 09 Sep 2020.
AGM
Avolife Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Avolife Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi Ii.
Appointed
Kaisvinder Singh Cheema was appointed as Director.
Appointed
Sukhwant Singh was appointed as Director.
Incorporation
09 Sep 2020
Avolife Pharmaceutical Private Limited was registered on 09 Sep 2020 with Roc Delhi Ii & aged 6 years 1 month as per MCA records.
Frequently asked questions
Avolife Pharmaceutical is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 September 2020 (6+ years old) and is registered under CIN U24290DL2020PTC369596.
Avolife Pharmaceutical has 2 current directors:
- Sukhwant Singh - Director
- Kaisvinder Singh Cheema - Director
The latest financial statements of Avolife Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Avolife Pharmaceutical is 07AAUCA0093Q1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Avolife Pharmaceutical is U24290DL2020PTC369596. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avolife Pharmaceutical was incorporated on 09 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Avolife Pharmaceutical by revenue are Cistron Healthcare and Allied Services Private Limited, Eyedent Enterprises Private Limited, Sabkhoj Foundation, Elaz@Yourhealth Private Limited, Bhoomi Ayurveda Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Kaisvinder Singh Cheema was appointed as Director on 09 Sep 2020. Sukhwant Singh was appointed as Director on 09 Sep 2020.
Yes, Avolife Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0005176).
The registered office of Avolife Pharmaceutical is at B – 52 Basement B – Block Community Center Janakpuri, Delhi, India – 110058.
Avolife Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.